You are here
ACCEL DIAGNOSTICS, LLC
UEI: QUJ4EFCK59N4
# of Employees: 5
HUBZone Owned: Yes
Socially and Economically Disadvantaged: Yes
Woman Owned: Yes
Award Charts
Award Listing
-
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
Amount: $1,060,897.00Summary In response to the COVID-19 pandemic and the increasing need of serological testing we propose the development and clinical validation of a novel serological blood test, RapidQCT™, to aid in ...
SBIRPhase II2022Department of Health and Human Services National Institutes of Health -
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
Amount: $240,405.00Summary In response to the COVID-19 pandemic and the increasing need of serological testing we propose the development and clinical validation of a novel serological blood test, RapidQCT™, to aid in ...
SBIRPhase I2021Department of Health and Human Services National Institutes of Health -
A rapid blood test to aid the triage of patients affected by head injuries.
Amount: $223,966.00Project Summary According to the CDC, in the U.S. over 2.8M emergency department visits are associated with Traumatic Brain Injury (TBI) each year, and over 288,000 result in patientsandapos; hospital ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
SBIR TOPIC 97- PHASE II- MINIMALLY INVASIVE TEST FOR CHEMOTHERAPY-INDUCED CARDIOTOXICITY
Amount: $727,427.00Cardiovascular toxicityCVTxis a serious short and long term complication of many anti cancer chemotherapeutic regimensZamoranoLancellotti et alIn this PhaseSBIR submission to continue the development ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
A Rapid Non-Invasive Device for Monitoring Preeclampsia inHigh Risk Pregnancy
Amount: $215,450.00Project Summary PreeclampsiaPEis a pregnancy specific life threatening disorder and one of the leading causes of maternal and fetal morbidity and mortalityIt is responsible for approximatelyof materna ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
A disposable assay for the monitoring of heart failure in the home setting.
Amount: $943,624.00Project Summary NIH SBIR Phase IIJanApplication TitleA disposable assay for the monitoring of heart failure at the point of careAccel DiagnosticsLLC Contact PIAlberto GandiniPh DMBA The objective of t ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
I Corps Program for A rapid instrument free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood
Amount: $194,545.00DESCRIPTION provided by applicant The objective of this proposed SBIR Phase I is to complete the proof of principle of a novel blood based biomarker assay for the diagnosis and management of Sepsis ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
A disposable assay for the monitoring of heart failure in the home setting
Amount: $225,133.00DESCRIPTION provided by applicant The objective of this proposed SBIR Phase is to complete the clinical validation of a novel blood assay pScreen BNP tm for the monitoring and management of h ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Blood Filtration System for the Treatment of Severe Malaria Patients
Amount: $524,409.00****NOTICE: ABSTRACT EXTRACTED FROM APPLICATION FOR REPORTING CATEGORIES AND DISEASE CODING (RCDC). THIS TEXT HAS NOT BEEN PROOFED BY SRA. WHEN THE UPLOADED ABSTRACT IS NOT IN THE EXPECTED FORMAT, THE ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health